Zydus Lifesciences rose 1.70% to Rs 433.35 after the company received nil observations for pre-approval inspection conducted by US Food and Drug Administration (USFDA) at...
Continue ReadingContinuing to expand its presence in the diagnostics segment, pharma major Cipla launched a point-of-care testing device for various non-communicable diseases and other medical conditions.Another...
Continue ReadingDr. Reddy’s Laboratories Ltd. announced that it has launched Difluprednate Ophthalmic Emulsion 0.05%.This medication is used to treat swelling and pain after eye surgery. It...
Continue ReadingGytree.com announced its first round of fundraising, led by Biocon’s Kiran Mazumdar Shaw, Rainmatter Investments, Ajay Srinivasan former CEO of Aditya Birla Capital, Anubhuti Sharma...
Continue ReadingLupin, a transnational pharmaceutical company announced that it had received tentative approval from the United States Food and Drug Administration (USFDA) to market its generic...
Continue ReadingDr. Reddy’s Laboratories Ltd. announced that it has acquired the trademark rights of the breast cancer drug Primcyv from Pfizer ProductsIndia Pvt Ltd for use...
Continue ReadingThe world’s first intranasal vaccine, christened as iNcovacc, is based on a delivery vehicle, a virus, that causes the common cold (adenovirus vector). The spike...
Continue ReadingPharmaceutical major Cipla NSE 0.46 % announced that its wholly-owned UK subsidiary Cipla (EU) Limited has signed definitive agreements to invest 15 million euros in...
Continue ReadingApproving Sun Pharma’s proposal to amend the existing clinical trial protocol for the atypical antipsychotic Pimavanserin Capsules, the Subject Expert Committee (SEC) functional under the...
Continue Reading